GPT-5 lowers the cost of cell-free protein synthesis

An autonomous laboratory system combining OpenAI's GPT-5 with Ginkgo Bioworks' cloud automation platform achieved a 40% reduction in cell-free protein synthesis costs through closed-loop experimentation. This breakthrough demonstrates AI's potential to significantly optimize biotechnology processes and reduce manufacturing expenses.